As of 2025-11-07, the EV/EBITDA ratio of Exagen Inc (XGN) is -18.00. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XGN's latest enterprise value is 221.30 mil USD. XGN's TTM EBITDA according to its financial statements is -12.30 mil USD. Dividing these 2 quantities gives us the above XGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.1x - 9.9x | 9.0x |
| Forward P/E multiples | 8.6x - 10.4x | 9.8x |
| Fair Price | (4.51) - (5.20) | (4.92) |
| Upside | -143.4% - -150.1% | -147.4% |
| Date | EV/EBITDA |
| 2025-11-05 | -17.91 |
| 2025-11-04 | -18.69 |
| 2025-11-03 | -20.59 |
| 2025-10-31 | -20.30 |
| 2025-10-30 | -20.46 |
| 2025-10-29 | -20.62 |
| 2025-10-28 | -20.70 |
| 2025-10-27 | -20.73 |
| 2025-10-24 | -20.82 |
| 2025-10-23 | -20.75 |
| 2025-10-22 | -20.45 |
| 2025-10-21 | -20.34 |
| 2025-10-20 | -20.39 |
| 2025-10-17 | -20.07 |
| 2025-10-16 | -20.48 |
| 2025-10-15 | -20.75 |
| 2025-10-14 | -20.07 |
| 2025-10-13 | -19.18 |
| 2025-10-10 | -19.01 |
| 2025-10-09 | -19.25 |
| 2025-10-08 | -19.07 |
| 2025-10-07 | -19.03 |
| 2025-10-06 | -18.93 |
| 2025-10-03 | -19.03 |
| 2025-10-02 | -18.91 |
| 2025-10-01 | -19.07 |
| 2025-09-30 | -19.09 |
| 2025-09-29 | -18.69 |
| 2025-09-26 | -18.91 |
| 2025-09-25 | -18.34 |
| 2025-09-24 | -18.71 |
| 2025-09-23 | -17.17 |
| 2025-09-22 | -17.05 |
| 2025-09-19 | -16.53 |
| 2025-09-18 | -16.69 |
| 2025-09-17 | -15.83 |
| 2025-09-16 | -15.72 |
| 2025-09-15 | -16.08 |
| 2025-09-12 | -16.85 |
| 2025-09-11 | -17.32 |
| 2025-09-10 | -16.65 |
| 2025-09-09 | -16.96 |
| 2025-09-08 | -16.98 |
| 2025-09-05 | -16.72 |
| 2025-09-04 | -17.01 |
| 2025-09-03 | -16.74 |
| 2025-09-02 | -16.62 |
| 2025-08-29 | -17.06 |
| 2025-08-28 | -16.85 |
| 2025-08-27 | -16.51 |